English | Spanish
ecancer
Supporting oncology professionals through education
Login Register

The content on this site is intended for healthcare professionals only

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

News

  • Latest news
  • Sign up for news alerts
  • Submit your news

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Journal information

  • Journal home
  • Charges
  • Editorial board
  • Founding editors
  • Editor-in-chief
  • Contact us

Author information

  • Submit article
  • Author guidelines
  • Editorial policies
  • Copyright information
  • Why publish with us

Reviewer information

  • Reviewer guidelines

Memberships

Open Access Scholarly Publishers Association Crossref Healthcare Information For All Commitee On Publication Ethics

Videos

  • Recent videos
  • Sign up

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Conferences

  • Latest conferences
  • Sign up for latest coverage
  • Submit your event

About ecancer

  • About ecancer
  • Our founders
  • Funding statement
  • Contact us
  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology
+ -
Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [1159]
News [2534]
Articles [157]
Editorials [8]
Conferences [104]
elearning [18]
Large population-based study suggests surveillance is a safe alternative to surgery for older patients with small kidney tumours
Large population-based study suggests surveillance is a safe alternative to surgery for older patients with small...
Duration of hormone therapy for high-risk prostate cancer can be shortened without  compromising treatment efficacy
Duration of hormone therapy for high-risk prostate cancer can be shortened without compromising treatment efficacy
Large study shows elderly and African-American men are at increased risk of having aggressive prostate cancer
Large study shows elderly and African-American men are at increased risk of having aggressive prostate cancer
Molecular subtypes of prostate cancer arise from different cell types
Molecular subtypes of prostate cancer arise from different cell types
Prostate cancer study tracks long-term urinary, sexual and bowel function side effects
Prostate cancer study tracks long-term urinary, sexual and bowel function side effects
Cancer death rates over a third higher in men than women
Cancer death rates over a third higher in men than women
Meta-analysis confirms folic acid supplementation unlikely to increase cancer risk
Meta-analysis confirms folic acid supplementation unlikely to increase cancer risk
Baldness at 40 linked to prostate cancer
Baldness at 40 linked to prostate cancer
Abiraterone acetate approved in the EU for use in the treatment of metastatic castration-resistant prostate cancer before chemotherapy
Abiraterone acetate approved in the EU for use in the treatment of metastatic castration-resistant prostate cancer...
Prostate cancer lifetime risk trebles in 25 years
Prostate cancer lifetime risk trebles in 25 years
<1...206207208209210...254>

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Desktop Site
  • Privacy Policy
© 2025 ecancer, all rights reserved
UK registered charity number: 1176307
Back to Top